Not many people are better equipped to dissect the food system than Stuart Gillespie. He has spent the past four decades ...

The emergence of the COVID-19 pandemic in 2020 shed a light on, and exacerbated, many health inequalities that were in some ...

Synthetic nicotine analogues are a new class of compounds making their way into the European and US vaping markets, raising urgent questions about public health, regulation, and scientific research.1 ...

Continuous exposure to AI might reduce the ADR of standard non-AI assisted colonoscopy, suggesting a negative effect on ...

Language in reproductive health care, unlike elsewhere, has always defaulted to using the words woman and women due to the historic invisibility of pregnant transgender, non-binary, and gender-diverse ...

Meru Sheel probably grew up in one of the most pro-women homes in New Delhi, India, with both her parents involved in women's advocacy and her father working in girls’ and women's education. “We would ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies ...

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

The Review by Stefanie Deinhardt-Emmer and colleagues1 on sepsis in patients who are immunocompromised is comprehensive and addresses a key and complex population. However, we would like to express ...

There are approximately 500 000 new cases of rifampicin-resistant or multidrug-resistant (RR/MDR) tuberculosis every year. In 2022, WHO recommended the all-oral bedaquiline, pretomanid, linezolid ...

Gaza's maternal and neonatal health sector was sliding from crisis towards collapse,1 fresh field reports reveal an even starker picture. In the first 6 months of 2025, the Palestinian Ministry of ...